FDA panel backs much-debated ALS drug in rare review

A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig’s disease.

Share this:

What do you think?

Leave a Reply

Your email address will not be published. Required fields are marked *

Written by Headlines

Mainstream media is often "Fake News." Nevertheless, one needs to see what others are seeing and then read with discernment.

Fairview Fire at 9,846 acres, 5% contained with 2 fatalities

China’s foreign firms, struggling to survive, hunker down for whatever comes next